Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
265.22
-5.23 (-1.93%)
At close: Jul 13, 2026, 4:00 PM EDT
264.00
-1.22 (-0.46%)
After-hours: Jul 13, 2026, 5:55 PM EDT
Ascendis Pharma Market Cap
Ascendis Pharma has a market cap or net worth of $16.47 billion as of July 13, 2026.
Market Cap
16.47B
Enterprise Value
16.85B
1-Year Change
n/a
Ranking
Category
Stock Price
$265.22
Market Cap Chart
Since April 20, 2026, Ascendis Pharma's market cap has increased from $15.16B to $16.47B, an increase of 8.67%. That is a compound annual growth rate of 43.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 16.47B | -1.93% |
| Jul 10, 2026 | 16.80B | -1.81% |
| Jul 9, 2026 | 17.11B | -0.63% |
| Jul 8, 2026 | 17.22B | 3.82% |
| Jul 7, 2026 | 16.58B | -0.35% |
| Jul 6, 2026 | 16.64B | -2.40% |
| Jul 2, 2026 | 17.05B | 2.51% |
| Jul 1, 2026 | 16.63B | 0.40% |
| Jun 30, 2026 | 16.57B | 1.15% |
| Jun 29, 2026 | 16.38B | 1.13% |
| Jun 26, 2026 | 16.20B | -0.32% |
| Jun 25, 2026 | 16.25B | 9.90% |
| Jun 24, 2026 | 14.78B | -0.24% |
| Jun 23, 2026 | 14.82B | 4.64% |
| Jun 22, 2026 | 14.16B | -1.23% |
| Jun 18, 2026 | 14.34B | -0.14% |
| Jun 17, 2026 | 14.36B | -0.02% |
| Jun 16, 2026 | 14.36B | 3.54% |
| Jun 15, 2026 | 13.87B | 2.40% |
| Jun 12, 2026 | 13.54B | 1.14% |
| Jun 11, 2026 | 13.39B | 2.77% |
| Jun 10, 2026 | 13.03B | -1.61% |
| Jun 9, 2026 | 13.24B | 3.61% |
| Jun 8, 2026 | 12.78B | -2.20% |
| Jun 5, 2026 | 13.07B | -3.83% |
| Jun 4, 2026 | 13.59B | 0.95% |
| Jun 3, 2026 | 13.47B | 0.09% |
| Jun 2, 2026 | 13.45B | -1.01% |
| Jun 1, 2026 | 13.59B | -2.36% |
| May 29, 2026 | 13.92B | -5.63% |
| May 28, 2026 | 14.75B | 0.94% |
| May 27, 2026 | 14.61B | -1.83% |
| May 26, 2026 | 14.89B | -3.00% |
| May 22, 2026 | 15.34B | -0.19% |
| May 21, 2026 | 15.37B | 2.56% |
| May 20, 2026 | 14.99B | 1.41% |
| May 19, 2026 | 14.78B | 0.14% |
| May 18, 2026 | 14.76B | -1.19% |
| May 15, 2026 | 14.94B | -2.03% |
| May 14, 2026 | 15.25B | 0.78% |
| May 13, 2026 | 15.13B | 2.50% |
| May 12, 2026 | 14.76B | -0.43% |
| May 11, 2026 | 14.82B | - |
| May 8, 2026 | 14.82B | -3.04% |
| May 7, 2026 | 15.29B | 4.90% |
| May 6, 2026 | 14.57B | 4.71% |
| May 5, 2026 | 13.92B | -1.50% |
| May 4, 2026 | 14.13B | 3.52% |
| May 1, 2026 | 13.65B | -3.68% |
| Apr 30, 2026 | 14.17B | 4.13% |
| Apr 29, 2026 | 13.61B | -0.81% |
| Apr 28, 2026 | 13.72B | -2.02% |
| Apr 27, 2026 | 14.00B | -1.14% |
| Apr 24, 2026 | 14.16B | 1.90% |
| Apr 23, 2026 | 13.90B | -2.62% |
| Apr 22, 2026 | 14.27B | -3.85% |
| Apr 21, 2026 | 14.85B | -2.07% |
| Apr 20, 2026 | 15.16B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Insmed | 23.48B |
| Incyte | 22.93B |
| BioNTech SE | 22.93B |
| Genmab | 17.82B |
| BridgeBio Pharma | 16.04B |
| Jazz Pharmaceuticals | 14.92B |
| Exelixis | 14.03B |
| Madrigal Pharmaceuticals | 12.26B |